Saturday, July 25, 2026

pharma · Juvenile idiopathic arthritis · juvenile idiopathic arthritis

Alfasigma

Alfasigma patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

BOLOGNA, IT HQ
2,481 Employees
EMA registrant Type
Company details
Intelligence · Patents

Alfasigma patents

1 pharmaceutical patents indexed for Alfasigma. 0 expire within 24 months.

Alfasigma has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2026027669

    BIOMARQUEURS POUR DÉTERMINER LE TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AVEC DU FILGOTINIB

    Expires Wed Jan 31 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Alfasigma have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Alfasigma patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.